Vaccine makers reduce research efforts and lay off employees

A group of scientists in lab coats discusses data in a vaccine research facility, surrounded by equipment and charts reflecting recent budget cuts and layoffs in the pharmaceutical industry.

The changes come amid a broader trend in the pharmaceutical industry, where companies are reevaluating their investment in vaccine development. According to reports, Pfizer plans to reduce its workforce by up to 20% in certain divisions, while Moderna has already laid off approximately 100 employees as part of its restructuring efforts. These decisions reflect the … Read more

Vaccine makers reduce research efforts and lay off employees

A group of scientists in lab coats discusses research data in a hightech laboratory, surrounded by vaccine development equipment and charts reflecting recent budget cuts.

As of October 2023, Pfizer has confirmed the elimination of approximately 2,000 jobs, primarily within its research and development divisions. Similarly, Moderna has indicated a 25% reduction in its workforce, a move that reflects the company’s need to adjust to a post-pandemic market. These decisions come at a time when funding for vaccine research is … Read more